Progestin facilitation of lordosis in rodents involves adenylyl cyclase activity in the ventral tegmental area

Hormones and Behavior
Cheryl A FryeSandra M Petralia

Abstract

Increasing cAMP, or activating dopamine type 1 (D(1)) or GABA(A)/benzodiazepine receptor complexes (GBRs), in the ventral tegmental area (VTA) enhances lordosis of rodents. Whether D(1)- and/or GBR-mediated increases in progestin-facilitated lordosis involve the cAMP-synthesizing enzyme, adenylyl cyclase, in the VTA, was investigated. In Experiment 1, ovariectomized estradiol (E(2); 10 microg at h 0)+progesterone (P; 250 microg at h 45)-primed hamsters first received bilateral infusions of the adenylyl cyclase inhibitor, 2',5'-dideoxyadenosine (DDA; 12 microM/side), or vehicle, and then were infused with the D(1) agonist, SKF38393 (100 ng/side), the GBR agonist, muscimol (100 ng/side), or vehicle, to the VTA. Lordosis was evaluated before and 30 min after each infusion. In Experiment 2, ovariectomized, E(2)-primed (10 microg at h 0) rats received VTA infusions of DDA (12 microM/side) or vehicle; SKF38393 (100 ng/side), muscimol (100 ng/side), or vehicle; and the neurosteroid, 5alpha-pregnan-3alpha-ol-20-one (3alpha,5alpha-THP; 100 or 200 ng/side), or beta-cyclodextrin vehicle. Lordosis was assessed before the series of infusions, immediately after drug infusions and 10 or 60 min after 3alpha,5alpha-THP infusions. Progestin- or ...Continue Reading

References

Jul 1, 1976·Scientific American·B S McEwen
Nov 1, 1976·Journal of Steroid Biochemistry·C BeyerP Söderstein
Jan 1, 1992·Neuron·D S Bredt, S H Snyder
Aug 1, 1992·Pharmacology, Biochemistry, and Behavior·C A Frye, J F DeBold
Jan 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·D S Bredt, S H Snyder
Jan 1, 1986·Neuroscience and Biobehavioral Reviews·R E Whalen, A H Lauber
Oct 1, 1985·Pharmacology, Biochemistry, and Behavior·M L ColladoM L Cruz
Jan 1, 1984·Annual Review of Psychology·H H Feder
Dec 3, 1984·Life Sciences·J C Stoof, J W Kebabian
Jul 5, 1994·Proceedings of the National Academy of Sciences of the United States of America·S K ManiJ H Clark
Feb 7, 1998·Proceedings of the National Academy of Sciences of the United States of America·T BlankJ Spiess
Jul 4, 1998·Brain Research. Brain Research Reviews·P GreengardA Nishi
Feb 27, 1999·Journal of Neuroendocrinology·H P ChuA M Etgen
Apr 10, 1999·Brain Research·M I Al-DahanR H Thalmann
Dec 9, 2000·Physiology & Behavior·S M Ramos, J F DeBold
Aug 8, 2001·Journal of Neuroscience Methods·B H Westerink, J B De Vries
Feb 26, 2003·Proceedings of the National Academy of Sciences of the United States of America·Yong ZhuPeter Thomas
Mar 1, 1964·Canadian Journal of Psychology·R D MYERS
Mar 31, 2004·Cellular and Molecular Neurobiology·Fumie YasumotoYasuhiro Yoshikawa
Jul 15, 2004·Pharmacology, Biochemistry, and Behavior·Cheryl A FryeKanako Sumida

❮ Previous
Next ❯

Citations

Jun 24, 2011·Journal of Neuroendocrinology·Cheryl Anne Frye
Jan 23, 2013·Neuropharmacology·Nicole Carrier, Mohamed Kabbaj
Sep 19, 2006·Pharmacology, Biochemistry, and Behavior·Cheryl A Frye

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Barrel cortex

Here is the latest research on barrel cortex, a region of somatosensory and motor corticies in the brain, which are used by animals that rely on whiskers for world exploration.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.